Incidence of metabolic syndrome and its risk factors among type 2 diabetes clinic attenders in Isfahan, Iran

Endokrynologia Polska

Volumn 63, Issue 5, 2012, Pages 372-380

  Janghorbani, Mohsen ^a,b   Amini, Masoud ^b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diabetes; Incidence; Metabolic syndrome; Risk factors

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ADULT; ARTICLE; BODY MASS; CLINICAL ASSESSMENT; DISEASE COURSE; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION SYSTEM; METABOLIC SYNDROME X; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT EDUCATION; PREDICTIVE VALUE; PREVALENCE; RISK FACTOR; WAIST CIRCUMFERENCE;

ADULT; BODY COMPOSITION; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FEMALE; HUMANS; INCIDENCE; INSULIN; IRAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS; WAIST CIRCUMFERENCE;

EID: 84870906916     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Ecket RH, Grundy SM, Zimmer PZ. The metabolic syndrome. Lancet 2005; 365: 1415-1428. (Pubitemid 40523737)
2. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among US adults. Diabetes Care 2004; 27: 2444-2449. (Pubitemid 39281399)
3. Nesto RW. Correlation between cardiovascular disease and diabetes mellitus: current concepts. Am J Med 2004; 116 (Suppl. 5A): 11S-22S. (Pubitemid 38333037)
4. Ridker PM, Buring JE, Cook NR et al. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14719 initially healthy American women. Circulation 2003 28; 107: 391-397.
5. Dekker GM, Girman CJ, Rhodes T et al. Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation 2005; 112: 666-673. (Pubitemid 41099045)
6. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005; 28: 1769-1778. (Pubitemid 40923091)
7. Wild S, Roglic G, Green A et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-1053. (Pubitemid 38579764)
8. Janghorbani M, Amini M. Metabolic syndrome in type 2 diabetes mellitus in Isfahan, Iran: prevalence and risk factors. Metab Syndr Relat Disord 2007; 5: 243-254. (Pubitemid 47402030)
9. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-359. (Pubitemid 34251969)
10. Alexander CM, Landsman PB, Teutsch SM et al. Third National Health and Nutrition Examination Survey (NHANES III); National Cholesterol Education Program (NCEP). NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003; 52: 1210-1214. (Pubitemid 36523358)
11. Janghorbani M, Amini M, Ghanbari H et al. Incidence of and risk factors for diabetic retinopathy in Isfahan, Iran. Ophthalmic Epidemiology 2003; 10: 81-95. (Pubitemid 36408313)
12. Janghorbani M, Amini M. Cataract in type 2 diabetes mellitus in Isfahan, Iran: Incidence and risk factors. Ophthalmic Epidemiology 2004; 11: 347-358. (Pubitemid 40095929)
13. American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2008; Suppl. 1: S55-60.
14. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NECP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
15. Sattar N, Gaw A, Scherbakova O et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003; 108: 414-419. (Pubitemid 36935533)
16. Li Y, Yatsuya H, Iso H et al. Incidence of metabolic syndrome according to combinations of lifestyle factors among middle-aged Japanese male workers. Prev Med 2010; 51: 118-122.
17. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1971; 18: 499-502.
18. Bonora E, Kiechl S, Willeit J et al. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes 1998; 47: 1643-1649. (Pubitemid 28445355)
19. Rantala AO, Kauma H, Lilja M et al. Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects. Journal of Internal Medicine 1999; 245: 163-174. (Pubitemid 29089113)
20. Fakhrzadeh H, Ebrahimpour P, Pourebrahim R et al. Metabolic syndrome and its associated risk factors in healthy adults: a population-based study in Iran. Metab Syndr Relat Disord 2006; 4: 28-34.
21. Azizi F, Salehi P, Etemadi A et al. Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract 2003; 61: 29-37. (Pubitemid 36808841)
22. Balkau B, Charles MA, Drivsholm T et al. European Group for the Study of Insulin Resistance (EGIR). Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab 2002; 28: 364-376. (Pubitemid 35434310)
23. Costa LA, Canani LH, Lisboa HR et al. Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in Type 2 diabetes. Diabet Med 2004; 21: 252-255. (Pubitemid 38299619)
24. Lee YJ, Tsai JC. ACE gene insertion/deletion polymorphism associated with 1998 World Health Organization definition of metabolic syndrome in Chinese type 2 diabetic patients. Diabetes Care 2002; 25: 1002-1008. (Pubitemid 41110485)
25. Ilanne-Parikka P, Eriksson JG, Lindstrom J et al. Prevalence of the metabolic syndrome and its components: findings from a Finnish general population sample and the Diabetes Prevention Study cohort. Diabetes Care 2004; 27: 2135-2140. (Pubitemid 39167175)
26. Nakanishi N, Suzuki K, Tatara K. Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men. Diabetes Care 2004; 27: 1427-1432. (Pubitemid 38679993)
27. Santos AC, Severo M, Barros H. Incidence and risk factors for the metabolic syndrome in an urban South European population. Prev Med 2010; 50: 99-105.
28. Scuteri A, Morrell CH, Najjar SS et al. Longitudinal paths to the metabolic syndrome: can the incidence of the metabolic syndrome be predicted? The Baltimore Longitudinal Study of Aging. J Gerontol A Biol Sci Med Sci 2009; 64: 590-598.
29. Palaniappan L, Carnethon MR, Wang Y et al. Insulin Resistance Atherosclerosis Study. Predictors of the incident metabolic syndrome in adults. The Insulin Resistance Atherosclerosis Study. Diabetes Care 2004; 27: 788-793. (Pubitemid 38280551)
30. Han TS, Williams K, Sattar N et al. Analysis of obesity and hyperinsulinemia in the development of metabolic syndrome: San Antonio Heart Study. Obes Res 2002; 10: 923-931. (Pubitemid 135688906)
31. Ryu S, Song J, Choi BY et al. Incidence and risk factors for metabolic syndrome in Korean male workers, ages 30 to 39. Ann Epidemiol 2007; 17: 245-252. (Pubitemid 46454381)
32. Fonseca VA. The metabolic syndrome, hyperlipidemia, and insulin resistance. Clin Cornerstone 2005; 7: 61-72. (Pubitemid 43205324)
33. Carnethon MR, Loria CM, Hill GO et al. Risk factors for the metabolic syndrome: The Coronary Artery Risk Development in Young Adults (CARDIA) study, 1985-2001. Diabetes Care 2004; 27: 2707-2715. (Pubitemid 39441474)
34. Sheu WHH, Chuang SY, Lee WJ et al. Predictors of incident diabetes, metabolic syndrome in middle-aged adults: A 10-year follow-up study from Kinmen. Taiwan Diabetes Res Clin Pract 2006; 74: 162-168.
35. Balkau B, Vernay M, Mhamdi L et al. The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French DESIR study. Diabetes Metab 2003; 29: 526-532. (Pubitemid 37474265)
36. Amini M, Bashardost N, Kazemi M et al. Risk factors of diabetes mellitus among Isfahan city population aged over 40. Res Med Sci J (Farsi) 1998; 2: 3-7.
37. Kissebah AH, Vydelingum N, Murray R et al. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 1982; 54: 254-260. (Pubitemid 12006594)
38. Krotkiewski M, Bjorntorp Psjostrom L, Smith U. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J Clin Invest 1983; 72: 1150-1162. (Pubitemid 14212633)
39. Examination Committee of Criteria for 'Obesity Disease' in Japan; Japan Society for the Study of Obesity. New criteria for 'obesity disease' in Japan. Circ J 2002; 66: 987-992.